Tolerance Faecalibacterium prausnitzii Epidemiology Metastatic melanoma Screening Circulating tumor DNA Carbapenem resistance Antimicrobial therapy Breast cancer screening Analgesia Merkel cell carcinoma Skin cancer Acinetobacter pittii Circulating tumour DNA Inflammation Cutibacterium Propionibacterium acnes Extracellular vesicles Colonization Early detection of cancer Biofilms ABO blood group Antibiotic resistance Lebanon Dendritic cells Diagnosis Acinetobacter baumannii Animals Acne Antibodies Adverse events Anti-CTLA-4 Bacteria Infection BRAF inhibitor Overall survival Transplantation Microbiota Abscess Clinical trial Norovirus Mélanome Cystic fibrosis Effectiveness Cytotoxicity Buruli ulcer Fucosylation Colorectal cancer Immunogenicity Immunothérapie Infective endocarditis Biomarkers Public health Case report Prevention FUT2 Histo-blood group antigens SARS-CoV-2 Antimicrobial resistance Rotavirus Cutibacterium acnes Cationic lipids Anti-PD1 Staphylococcus aureus Quality of life Alzheimer's disease Elderly Anxiety COVID-19 Brain injury Immune checkpoint inhibitor Pembrolizumab Skin France Autoimmunity Antimicrobial peptides Adoptive cell transfer Bone and joint infection Immunology Anti-PD-1 Immune checkpoint inhibitors BRAF mutation PD-1 Cutaneous squamous cell carcinoma Wood Mycolactone Ipilimumab Immunotherapy Cancer Mycobacterium ulcerans Primary care Prognosis T cells Truncal acne Fucose Nivolumab Evolution Melanoma Biomarker Biofilm Costimulation blockade